drugset / Trial / NCT04777643
Sex Differences in Neural Response to Cannabidiol
RandomizedCrossoverTriple-blindBasic science
Summary
This is a randomized, double-blind, within-subjects, cross-over design to assess neural changes following a single dose of cannabidiol (CBD) (600mg) versus placebo among healthy female volunteers.
Timeline
- Start
- 2022-06-07
- Primary completion
- 2023-04-27
- Completion
- 2023-04-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 600 mg | Oral |
Indications
No indication recorded.